From Washington to Wall Street, it's a crazy time for biotech. But as Ultragenyx Pharmaceutical Inc. celebrates its 15th ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

Born in Mumbai, Reshma moved to the United States in 1988. She pursued a career in medicine, earning her degree from Boston University, followed by a fellowship at Massachusetts General Hospital.

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

Find out what makes Basel's biotech hub so successful, as it has cemented its place as one of Europe's brightest life ...

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...

The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer ...

This plant is approvable by leading global regulatory agencies such as USFDA, EDQM, PMDA, TGA etc. Last checked, the market capitalisation of Medicamen Biotech stood at Rs 674.32 crore, BSE data ...

Moleculin Biotech has begun dosing subjects in a Phase III trial of Annamycin with Cytarabine for treating acute myeloid ...